7 years ago

Tropic Biosciences Raises $10 Million to Advance Gene-Edited Crops

  • Tropic Biosciences, a UK-based company developing new plant varieties in the tropical agriculture industry using CRISPR Gene Editing, has secured $10 million in Series A funding

  • The round was led by Pontifax AgTech and Five Seasons Ventures, with participation from several other investors

  • The funds will be used to commercialize the company's non-GMO coffee and banana varieties, expand into new crop segments, drive regulatory approvals, and continue developing proprietary technologies.

      • ProblemAgriculture

      "Farmers are struggling to grow profitable and sustainable coffee and banana crops due to disease, pests, and changing climate conditions."

      Solution

      "Tropic Biosciences uses CRISPR gene editing technology to develop new, more resilient coffee and banana varieties that are resistant to diseases and pests, require less water and pesticides, and produce higher yields."

      Covered on